Search results
Results from the Health.Zone Content Network
McKesson Corporation is a publicly-traded American company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceuticals used in North America and employs over 51,000 employees.
McKesson would acquire about a 70% stake in the unit, which would be part of its U.S. pharmaceutical segment. Upon the close of the transaction, Florida Cancer Specialists — which operates in ...
covermymeds.com. CoverMyMeds is a healthcare software company that creates software to automate the prior authorization process used by some health insurance companies in the United States. The company was founded in 2008 and has offices in Ohio. Since early 2017, it has operated as a wholly owned subsidiary of McKesson Corporation.
John Hammergren. (1959-02-20) 20 February 1959 (age 65) Saint Paul, Minnesota, U.S. Occupation (s) CEO of McKesson Corporation, Retired. John H. Hammergren is an American businessman. He is best known for his role as chairman and CEO of McKesson Corporation since 1999. [1] On November 1, 2018, Hammergren announced his plan to retire. [2]
McKesson Corporation, currently ranked 14th on the FORTUNE 500, is a healthcare services and information technology company dedicated to making the business of healthcare run better.
On Wednesday, health-care services and IT firm McKesson Corporation (NYS: MCK) confirmed it has received notification of the early termination of the Hart-Scott-Rodino waiting period required ...
McKesson Europe AG (formerly Celesio AG, previously Gehe AG), with its headquarters in Stuttgart, Germany, is a leading international wholesale and retail company and provider of logistics and services in the pharmaceutical and healthcare sectors. The company had around 37,000 employees at the end of the 2019 financial year (31 March 2019) and ...
McKesson Reports Fiscal 2013 Fourth-Quarter and Full-Year Results Revenues of $30.6 billion for the fourth quarter and $122.5 billion for the full year. Fourth-quarter GAAP earnings per diluted ...